Akèy › Kansè pwostat › Pennsylvania › Lancaster
Etid klinik pou Kansè pwostat nan Lancaster, PA
4 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Lancaster (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Ap rekriteFaz 3
- The Centers for Advanced Urology d/b/a Keystone Urology Specialist, Lancaster
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Ap rekriteFaz 3
- Research Site, Lancaster
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Ap rekriteFaz 2
- Lancaster Urology, Lancaster
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Ap rekriteFaz 1
- Keystone Urology Specialists, Lancaster
Etid Kansè pwostat nan lòt vil
- New York City, NY103 etid
- Houston, TX76 etid
- Los Angeles, CA61 etid
- Boston, MA59 etid
- St. Louis, MO46 etid
- Chicago, IL45 etid
- San Francisco, CA45 etid
- Philadelphia, PA44 etid
- Baltimore, MD43 etid
- Nashville, TN42 etid
- Seattle, WA42 etid
- Washington, DC38 etid
Lòt etid nan Lancaster
- Kansè Poumon ki pa ti selil7 etid
- Ensifizyans kadyak5 etid
- Maladi kadyovaskilè5 etid
- Kansè Metastatik4 etid
- Kansè nan tete4 etid
- Kansè poumon3 etid
- Kansè vejik3 etid
- Amblyopi3 etid
- Maladi kè3 etid
- Kansè Vezik ki pa envazif miskilè3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.